Science ❯ Research ❯ Clinical Trials
Triple-Negative Breast Cancer Metabolic Dysfunction Pancreatic Cancer Research Personalized Medicine Ovarian Cancer Detection Next-Generation Drugs Drug Resistance
The preclinical study reports restored chemotherapy response in lung squamous cell carcinoma after disabling a tumor-specific NRF2 mutation.
